(Q33998315)

30 July 2017

1 reference

title

Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia (English)

1 reference

30 July 2017

0 references

1 reference

1 reference

1 reference

1

Drexler HG

1 reference

30 July 2017

Matsuo Y

2

1 reference

PubMed ID

10936422

30 July 2017

language of work or name

1 reference

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

24

1 reference

30 July 2017

681-703

1 reference

30 July 2017

8

1 reference

PubMed ID

10936422

describes a project that uses

30 July 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Bone marrow microenvironment and the progression of multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

The involvement of adhesion molecules in the biology of multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Biological aspects of multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

The role of adhesion molecules in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Multiple myeloma: prognosis and standard treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Leukemia cell lines: in vitro models for the study of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Interleukins and colony stimulating factors in human myeloid leukemia cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Cytokine response profiles of human myeloid factor-dependent leukemia cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Malignant hematopoietic cell lines: in vitro models for the study of myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment and characterization of human B cell precursor-leukemia cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Cytogenetic and biological characterization of two new human plasma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

IgD myeloma presenting as a testicular tumor: establishment and characterization of an IgD-secreting myeloma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

A novel mature B-cell line (DOBIL-6) producing both parathyroid hormone-related protein and interleukin-6 from a myeloma patient presenting with hypercalcaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Characterization of new IgG lambda myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

A human plasma cell line: induction and characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment and characterization of a plasma cell leukaemia cell line dependent for growth on IL-6 and a bi-phenotypic subclone dependent upon both IL-3 and IL-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

A new human plasma cell line, Karpas 620, with translocations involving chromosomes 1, 11 and 14.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Human myeloma cell line carrying a Philadelphia chromosome.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Human plasmacytoma with an unusual karyotype growing in vitro and producing light-chain immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment and characterization of a human myeloma cell line (KMM-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment of five human myeloma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: A comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment and characterization of a permanent human IgA2/kappa myeloma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2).

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment and characterization of a human IgA-kappa-secreting plasma cell line (MT3).

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Two distinct human myeloma cell lines originating from one patient with myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Characterization of a human plasmacytoma line.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

ARH-77, an established human IgG-producing myeloma cell line. I. Morphology, B-cell phenotypic marker profile, and expression of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

ARH-77, an established human IgG-producing myeloma cell line. II. Growth kinetics, clonogenic capacity, chalone production, xenogeneic transplantations, and response to melphalan

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

IgD on cell membranes of human lymphoid cell lines with multiple immunoglobulin classes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte-stimulating factor for the proliferation of myeloma cells in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Spontaneous secretion of tumor necrosis factor-beta by human myeloma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment and characterization of a human non-secretory plasmacytoid cell line and its hybridization with human B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Effect of the interaction between fibronectin and VLA-4 on the proliferation of human B cells, especially a novel human B-cell line, OPM-3

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment of a new human myeloma cell line (U-2030) and selection of a hat-sensitive subline.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Colony growth and self renewal of plasma cell precursors in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Classification and biological nature of established human hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

Establishment in continuous culture of a new type of lymphocyte from a “burkitt-like” malignant lymphoma (line d.g.-75)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900195-2

7 January 2021

10.1016/S0145-2126(99)00195-2

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10936422